93 related articles for article (PubMed ID: 21685679)
1. SPIO-RGD nanoparticles as a molecular targeting probe for imaging tumor angiogenesis using synchrotron radiation.
Li J; Zhang C; Yang K; Liu P; Xu LX
J Synchrotron Radiat; 2011 Jul; 18(Pt 4):612-6. PubMed ID: 21685679
[TBL] [Abstract][Full Text] [Related]
2. Modification of MR molecular imaging probes with cysteine-terminated peptides and their potential for in vivo tumour detection.
Xu F; Lei D; Du X; Zhang C; Xie X; Yin D
Contrast Media Mol Imaging; 2011; 6(1):46-54. PubMed ID: 20865697
[TBL] [Abstract][Full Text] [Related]
3. Tumor Angiogenesis Targeted Radiosensitization Therapy Using Gold Nanoprobes Guided by MRI/SPECT Imaging.
Yang Y; Zhang L; Cai J; Li X; Cheng D; Su H; Zhang J; Liu S; Shi H; Zhang Y; Zhang C
ACS Appl Mater Interfaces; 2016 Jan; 8(3):1718-32. PubMed ID: 26731347
[TBL] [Abstract][Full Text] [Related]
4. Specific targeting of angiogenesis in lung cancer with RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a 4.7T magnetic resonance scanner.
Liu C; Liu DB; Long GX; Wang JF; Mei Q; Hu GY; Qiu H; Hu GQ
Chin Med J (Engl); 2013 Jun; 126(12):2242-7. PubMed ID: 23786932
[TBL] [Abstract][Full Text] [Related]
5. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles.
Lee HY; Li Z; Chen K; Hsu AR; Xu C; Xie J; Sun S; Chen X
J Nucl Med; 2008 Aug; 49(8):1371-9. PubMed ID: 18632815
[TBL] [Abstract][Full Text] [Related]
6. Micro-CT molecular imaging of tumor angiogenesis using a magnetite nano-cluster probe.
Liu P; Li J; Zhang C; Xu LX
J Biomed Nanotechnol; 2013 Jun; 9(6):1041-9. PubMed ID: 23858968
[TBL] [Abstract][Full Text] [Related]
7. RGD-conjugated iron oxide magnetic nanoparticles for magnetic resonance imaging contrast enhancement and hyperthermia.
Zheng SW; Huang M; Hong RY; Deng SM; Cheng LF; Gao B; Badami D
J Biomater Appl; 2014 Mar; 28(7):1051-9. PubMed ID: 23796630
[TBL] [Abstract][Full Text] [Related]
8. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.
Fan C; Gao W; Chen Z; Fan H; Li M; Deng F; Chen Z
Int J Pharm; 2011 Feb; 404(1-2):180-90. PubMed ID: 21087660
[TBL] [Abstract][Full Text] [Related]
9. Spectroscopically well-characterized RGD optical probe as a prerequisite for lifetime-gated tumor imaging.
Mathejczyk JE; Pauli J; Dullin C; Napp J; Tietze LF; Kessler H; Resch-Genger U; Alves F
Mol Imaging; 2011 Dec; 10(6):469-80. PubMed ID: 22201538
[TBL] [Abstract][Full Text] [Related]
10. RGD peptide-conjugated multimodal NaGdF4:Yb3+/Er3+ nanophosphors for upconversion luminescence, MR, and PET imaging of tumor angiogenesis.
Lee J; Lee TS; Ryu J; Hong S; Kang M; Im K; Kang JH; Lim SM; Park S; Song R
J Nucl Med; 2013 Jan; 54(1):96-103. PubMed ID: 23232276
[TBL] [Abstract][Full Text] [Related]
11. Conjugation of iron oxide nanoparticles with RGD-modified dendrimers for targeted tumor MR imaging.
Yang J; Luo Y; Xu Y; Li J; Zhang Z; Wang H; Shen M; Shi X; Zhang G
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5420-8. PubMed ID: 25695661
[TBL] [Abstract][Full Text] [Related]
12. Morphological study of early-stage lung cancer using synchrotron radiation.
Liu P; Sun J; Guan Y; Yue W; Xu LX; Li Y; Zhang G; Hwu Y; Je JH; Margaritondo G
J Synchrotron Radiat; 2008 Jan; 15(Pt 1):36-42. PubMed ID: 18097076
[TBL] [Abstract][Full Text] [Related]
13. In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature.
Ma W; Li G; Wang J; Yang W; Zhang Y; Conti PS; Chen K
Amino Acids; 2014 Dec; 46(12):2721-32. PubMed ID: 25182731
[TBL] [Abstract][Full Text] [Related]
14. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.
Zhang C; Jugold M; Woenne EC; Lammers T; Morgenstern B; Mueller MM; Zentgraf H; Bock M; Eisenhut M; Semmler W; Kiessling F
Cancer Res; 2007 Feb; 67(4):1555-62. PubMed ID: 17308094
[TBL] [Abstract][Full Text] [Related]
15. MicroPET, MicroSPECT, and NIR fluorescence imaging of biomolecules in vivo.
Li ZB; Chen X
Methods Mol Biol; 2009; 544():461-81. PubMed ID: 19488719
[TBL] [Abstract][Full Text] [Related]
16. Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature.
Liu Z; Jia B; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F
Bioconjug Chem; 2010 Mar; 21(3):548-55. PubMed ID: 20184307
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer and angiogenesis imaging using synchrotron radiation.
Liu X; Zhao J; Sun J; Gu X; Xiao T; Liu P; Xu LX
Phys Med Biol; 2010 Apr; 55(8):2399-409. PubMed ID: 20360634
[TBL] [Abstract][Full Text] [Related]
18. A direct comparison of tumor angiogenesis with ⁶⁸Ga-labeled NGR and RGD peptides in HT-1080 tumor xenografts using microPET imaging.
Shao Y; Liang W; Kang F; Yang W; Ma X; Li G; Zong S; Chen K; Wang J
Amino Acids; 2014 Oct; 46(10):2355-64. PubMed ID: 24990522
[TBL] [Abstract][Full Text] [Related]
19. Imaging integrin αvβ3 on blood vessels with 111In-RGD2 in head and neck tumor xenografts.
Terry SY; Abiraj K; Frielink C; van Dijk LK; Bussink J; Oyen WJ; Boerman OC
J Nucl Med; 2014 Feb; 55(2):281-6. PubMed ID: 24408894
[TBL] [Abstract][Full Text] [Related]
20. [Optimal concentration of c-erbB2 antisense probe labeled with superparamagnetic iron oxide nanoparticles for magnetic resonance imaging in tumor-bearing nude mice].
Wen Z; Liu H; Wen M; He H; Tan S; Li S
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):496-501. PubMed ID: 23644106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
